Search research articles
Contact Us
Filters
Showing results (51-60 of 109) with videos related to
Page
of 11
Sort By:
Oncology Letters
|
September 24, 2020
Establishment and characterization of a docetaxel-resistant human prostate cancer cell line
Jian Liu, Yujie Huang, Danyan Zhu, et al.
CNS Neuroscience & Therapeutics
|
October 16, 2020
A novel DNA repair-related nomogram predicts survival in low-grade gliomas
Guanzhang Li, Fan Wu, Fan Zeng, et al.
Drug Design, Development and Therapy
|
October 16, 2023
Effect of Food on the Pharmacokinetics of Tenofovir Amibufenamide: A Phase I, Randomized, Open-Label, Two-Period Crossover Trial in Healthy Adult Subjects
Jian Liu, Minglan Wu, Jiejing Kai, et al.
Antimicrobial Agents and Chemotherapy
|
March 11, 2020
Effects of Tenofovir on the Single-Dose Pharmacokinetics of Intravenous Morinidazole in Healthy Chinese Subjects
Guolan Wu, Wenling Tang, Duo Lv, et al.
Drug Design, Development and Therapy
|
September 2, 2025
Population Pharmacokinetic Modeling Analysis of ASC10, a Novel Antiviral Agent Targeted COVID-19, in Chinese Healthy Subjects
Duo Lv, Sichan Li, Yi Li, et al.
Journal of Analytical Methods in Chemistry
|
March 29, 2014
Simple and sensitive analysis of blonanserin and blonanserin C in human plasma by liquid chromatography tandem mass spectrometry and its application
Yunliang Zheng, Xingjiang Hu, Jian Liu, et al.
Drug Design, Development and Therapy
|
November 17, 2022
Targeting mTOR Complex 2 in Castration-Resistant Prostate Cancer with Acquired Docetaxel Resistance
Yujie Huang, You Zhai, Meijia Wu, et al.
Frontiers in Pharmacology
|
September 5, 2022
A single-dose, randomized, open-labeled, parallel-group study comparing the pharmacokinetics, pharmacodynamics and safety of leuprolide acetate microspheres 3.75 mg and Enantone<sup>®</sup> 3.75 mg in healthy male subjects
Xingjiang Hu, Qiao Zhang, Yunliang Zheng, et al.
Cancer Letters
|
February 14, 2025
The development and potent antitumor efficacy of CD44/CD133 dual-targeting IL7Rα-armored CAR-T cells against glioblastoma
You Zhai, Guanzhang Li, Changqing Pan, et al.
Drug Design, Development and Therapy
|
November 4, 2015
Safety and pharmacokinetics of dicloxacillin in healthy Chinese volunteers following single and multiple oral doses
Guolan Wu, Yunliang Zheng, Huili Zhou, et al.
Page
of 11
Search research articles
Search
Showing results (51-60 of 109) with videos related to
Sort By:
Page
of 11
Oncology Letters
|
September 24, 2020
Establishment and characterization of a docetaxel-resistant human prostate cancer cell line
Jian Liu, Yujie Huang, Danyan Zhu, et al.
CNS Neuroscience & Therapeutics
|
October 16, 2020
A novel DNA repair-related nomogram predicts survival in low-grade gliomas
Guanzhang Li, Fan Wu, Fan Zeng, et al.
Drug Design, Development and Therapy
|
October 16, 2023
Effect of Food on the Pharmacokinetics of Tenofovir Amibufenamide: A Phase I, Randomized, Open-Label, Two-Period Crossover Trial in Healthy Adult Subjects
Jian Liu, Minglan Wu, Jiejing Kai, et al.
Antimicrobial Agents and Chemotherapy
|
March 11, 2020
Effects of Tenofovir on the Single-Dose Pharmacokinetics of Intravenous Morinidazole in Healthy Chinese Subjects
Guolan Wu, Wenling Tang, Duo Lv, et al.
Drug Design, Development and Therapy
|
September 2, 2025
Population Pharmacokinetic Modeling Analysis of ASC10, a Novel Antiviral Agent Targeted COVID-19, in Chinese Healthy Subjects
Duo Lv, Sichan Li, Yi Li, et al.
Journal of Analytical Methods in Chemistry
|
March 29, 2014
Simple and sensitive analysis of blonanserin and blonanserin C in human plasma by liquid chromatography tandem mass spectrometry and its application
Yunliang Zheng, Xingjiang Hu, Jian Liu, et al.
Drug Design, Development and Therapy
|
November 17, 2022
Targeting mTOR Complex 2 in Castration-Resistant Prostate Cancer with Acquired Docetaxel Resistance
Yujie Huang, You Zhai, Meijia Wu, et al.
Frontiers in Pharmacology
|
September 5, 2022
A single-dose, randomized, open-labeled, parallel-group study comparing the pharmacokinetics, pharmacodynamics and safety of leuprolide acetate microspheres 3.75 mg and Enantone<sup>®</sup> 3.75 mg in healthy male subjects
Xingjiang Hu, Qiao Zhang, Yunliang Zheng, et al.
Cancer Letters
|
February 14, 2025
The development and potent antitumor efficacy of CD44/CD133 dual-targeting IL7Rα-armored CAR-T cells against glioblastoma
You Zhai, Guanzhang Li, Changqing Pan, et al.
Drug Design, Development and Therapy
|
November 4, 2015
Safety and pharmacokinetics of dicloxacillin in healthy Chinese volunteers following single and multiple oral doses
Guolan Wu, Yunliang Zheng, Huili Zhou, et al.
Page
of 11